Second Circuit Affirms Zyprexa Document Sanctions

Here’s the opinion.  The Drug & Device Law Blog has some analysis. I posted about the case extensively and wrote an article addressing issues of document leaks for The Review of Litigation as well. 

As readers may recall, David Egilman was a plaintiffs’ expert in the Zyprexa litigation and the courts concluded that he worked with Alaska attorney James Gottstein to make public documents designated as confidential under a protective order.  Dr. Egilman settled the potential contempt litigation with a donation to a charity and with an affidavit in which he acknowledged, under oath, violating the protective order, releasing documents selectively, and so on.  (The affidavit is here.)

–BC